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Diagnosis of infection with Chlamydia pneumoniae is difficult and the optimal diagnostic procedure has yet to be 
established. C. pneumoniae is more difficult to isolate in tissue culture than C. trachomatis. Attention must be paid to 
the site from which the specimen is taken, and all specimens should be processed within 24 h or stored at 4 OC. Serologic 
diagnosis largely depends on microimrnunofluorescence testing which, despite proposed criteria, still has a large 
subjective component. Serology has limitations in terms of both sensitivity and specificity and antibodies may be difficult 
to detect in individuals with positive C. pneumoniae cultures. Non-culture methods include enzyme immunoassays, 
fluorescent-antibody techniques and DNA probes. The most promising appears to be PCR. Co-infection of C. 
pneumoniae and other respiratory organisms seem to be common. 
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CHLA MYDIA PNEUMONIAE IN FECTlO N 
Chlamydia pneumoniae has emerged as a common cause 
of respiratory infection. Recent studies suggest that the 
organism is responsible for 10-20% of community- 
acquired pneumonia in adults and children and 10-20% 
of acute bronchitis in adults [1-4]. C. pneumoniae has 
also been implicated as an infectious trigger for asthma 
[5]. Infection with C. pneumoniae is fiequently sub- 
clinical and may persist for prolonged periods of time 
[6]. Chronic infection with C. pneumoniae has also been 
suggested as a factor in the development of athero- 
sclerotic heart disease [7]. 
Despite the increasing appreciation of its role as a 
respiratory pathogen, diagnosis of C. pneumoniae 
infection remains Micult, due in part to the limited 
availability of fachties capable of performing culture or 
serology and the lack of a commercially available rapid 
non-culture test. There is even controversy on which 
method would be the ‘gold standard’ for diagnosing 
infection. As infections with C. pneumoniae are treatable 
with antimicrobial agents, more attention has recently 
been directed to diagnosis. 
The first isolates of C. pneumoniae were seren- 
dipitously obtained during trachoma studies in the 
1960s [l]. Tw-183 was isolated &om the eye of a chdd 
with suspected trachoma in Taiwan, and IOL-207 was 
isolated fiom the eye of another child with trachoma 
fiom Teheran. Later, serologic studies of an outbreak of 
mild pneumonia among children in Finland in the 
1970s suggested that an organism related to TW-183 
was the cause [ 13. Originally the organism was difficult 
to grow in tissue culture; it could only be propagated 
in eggs. On the basis of inclusion morphology and 
failure to stain with iodine, TW-183 was initially 
considered to be a strain of C. psittaci [l]. Following 
recovery of similar isolates fiom the respiratory tracts of 
college students with pneumonia and bronchitis in 
Seattle, Grayston and colleagues demonstrated that the 
organism was distinct fiom both C. trachomatis and C. 
psittaci [ 11. Restriction endonuclease pattern analysis 
and nucleic acid hybridization studies suggest a high 
degree of genetic relatedness (>95%) among the C. 
pneumoniae isolates examined so far [l]. 
DIAGNOSTIC METHODS 
Culture of C. pneumoniae 
As previously stated, initial studies suggested that C. 
pneumoniae was very Micult to isolate in tissue culture 
compared with C. trachomatis. Kuo et al [8] reported 
that HeLa cells pretreated with DEAE-dextran were 
superior to McCoy cells for isolation and propagation 
of C. pneumoniae. Inclusions tended to be very s m a l l ,  
and experience in some clinical studies found that up 
to four serial passages, every 72 h, were needed to 
maximize the isolation rate [3]. Subsequent studies 
found that C. pneumoniae grows more readily in other 
cell lines derived fiom the human respiratory tract 
including HL, Hep-2 and H 292 cells [9-131. Hep-2 
s3 
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Table 1 C. pneumoniae culture 
1. Requires tissue culture (Hep-2, HL cells) 
2. Takes 3-7 days 
3. Culture confirmation by fluorescent-antibody staining with 
species-specific monoclonal antibody 
and H 292 cells appear to be the most sensitive for 
isolation of the organism &om clylical specimens and 
for propagation [ll-131. Use of DEAE-dextran is not 
necessary with these cell lines and actually results in 
smaller, less visible, inclusions [12]. Roblin et al [12] 
found that an initial inoculation and one passage in 
Hep-2 cells was equivalent to four serial passages in 
HeLa cells pretreated with DEAE-dextran. Culture 
confirmation is preferably performed by staining with 
a fluorescein-conjugated, species-specific monoclonal 
antibody (Table 1). However, these reagents are not 
readily available commercially. Thus, many laboratories 
use the more readily available genus-specific reagents 
Another factor that may influence the abhty to 
isolate C. pneumoniae from patients is the specimen site. 
Most studes done so far have used throat swabs. 
However, the posterior nasopharynx (") may be a 
superior site. As part of a multicenter pediatric 
pneumonia treatment study, duplicate specimens were 
obtained h m  the throat and N P  of a subgroup of the 
chlldren enrolled. Of the children who had C. 
pneumoniae isolated, all the Np cultures were positive, 
but only 50% of the throat swabs from the same 
children were positive [4]. NP cultures can be obtained 
with Dacron-tipped, wire-shafied swabs. 
The adhesive used to attach the Dacron to the swab 
shaft can change lot-to-lot, depending on what the 
manufacturer buys. Some adhesives can be toxic to the 
cells or inhibit the growth of C. pneumoniae. Thus each 
new lot of swabs, as well as fetal calf serum and media, 
should be tested to ensure that there is no dubition. 
Specimens for culture should be placed in appropriate 
transport media, usually a sucrose-phosphate buffer 
with antibiotics and fetal calfserum. Specimens should 
be stored immediately at 4°C. Viability may decrease if 
specimens are held at room temperature. If specimens 
cannot be processed with 24 h they should be frozen at 
-70 "C until culture can be performed. C. pneumoniae 
has also been isolated from sputum, bronchoalveolar 
lavage fluids and pleural fluids [ 1,15,16]. 
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Serology 
To date most investigations have relied on serologic 
diagnosis, using modifications of the microimmuno- 
fluorescence (MIF) test. Grayston and associates [l] 
have proposed criteria for serologic diagnosis of C. 
pneumoniae infection that have been used by many 
chcians (Table 2). For acute infection the patient 
should have a four-fold increase in the IgG titer, a 
single Igh4 titer 2 1:16, or a single IgG titer 1 1:512. 
Past or pre-existing infection is defined as an IgG 2 
1:16 and I 1:512. Rheumatoid factor may cause false- 
positive IgM titers in the MIF test and it has been 
recommended that sera, especially h m  older indi- 
viduals, be absorbed before testing [17]. Grayston [l] 
further proposed that the pattern of antibody response 
in primary infection may differ from that seen in 
reinfection. In initial infection, the IgM response 
appears about 3 weeks after the onset of illness and the 
IgG response at 6 to 8 weeks. In reinfection, the IgM 
response may be absent and the IgG response occurs 
earlier, usually within 1 to 2 weeks. The MIF test is 
mainly available in research laboratories. It is a ditficult 
test to perform, with a significant subjective com- 
ponent. 
Grayston and others have also suggested that a 
four-fold titer rise or a titer 2 1:64 with the Chlamydia 
complement-furation (CF) test could be diagnostic for 
C. pneumoniae dection (Table 2) [1,18]. The CF test 
is genus-specific, but is probably the most widely 
available serologic test for Chlamydia mfection. It has 
been used for many years for the diagnosis of psittacosis. 
It is possible that many cases of pneumonia, especially 
without a history of avian exposure, diagnosed as 
psittacosis on the basis of the CF test were probably due 
to C. pneumoniae [19-211. Early studies suggested that 
the CF test was more likely to be positive in the initial 
infection than during reinfection [l]. 
During an outbreak of C. pneumoniae dection at 
the University of Washington campus, all of eight 
culture- and/or polymerase chain reaction (FCR)- 
positive students with pneumonia or bronchtis had CF 
titers 1 1:64 [2]. There are several ELISA antibody tests 
that are being marketed for the diagnosis of chlamydial 
dections, primarily for C. trachomatis infection. 
Table 2 Serologic criteria for diagnosis of C. pneumoniae 
infection 
MIF 
Acute infection Four-fold rise IgG 
IgM Z 1:16 
IgG Z 1:512 
IgG 2 1:16, <512 Pre-existing antibody 
Chlamydia CFa 
Acutelinfection Four-fold rise 
Z 1:64 
"Genus specific 
From Grayston et al [l]. 
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Table 3 Correlation of C. pneumoniae serology and culture 
in children with community-acquired pneumonia 
C. pneumoniae culture 
Serology Positive Negative Total 
Acute 8 40 48 
Total 34 226 260 
From Block et a1 [4]. 
None/pre-existing 26 186 212 
However, these tests are genus-specific and have not 
been specifically evaluated for the diagnosis of C. 
pneumoniae infection. 
Grayston initially suggested that serology, using 
these criteria with the MIF test, was more sensitive than 
culture. However, it was noted by Chirgwin et al that 
some individuals with positive C. pneumoniae cultures 
and community-acquired pneumonia did not meet the 
serologic criteria even with multiple serum samples 
obtained over several months [3]. Some culture- 
positive chddren did not develop any detectable 
antibody by MIE In a multicenter pediatric pneumonia 
treatment study it was found that only eight of 34 (24%) 
of the children with culture-documented C. pneu- 
moniae infection met the serologic criteria for acute 
infection. The majority had no detectable MIF anti- 
body even after 3 months of follow-up (Table 3) [4]. 
These children were also negative with the CF test. 
Most of the culture-negative serologically positive 
children did not seroconvert or have a four-fold titer 
rise but had stable IgG titers 2 1:512. Kern et a1 [22] 
in a study of subjectively healthy adults (fire-fighters 
and policemen) found serologic evidence of recent C. 
pneumoniae infection (IgM 1 1:16 and/or IgG 1 
1:512) in 13% of their subjects. The overall sero- 
prevalence was 86%. They also found a strong 
correlation between IgM titers for C. pneurnoniae and 
C. trachomatis. Cultures for C. pneumoniae were not 
performed in this study. However, very similar results 
were reported recently by Hyman et al in a study of 
subjectively healthy adults, where culture and PCR for 
C. pneumoniae were employed (Table 4) [23]. They 
studied 104 healthcare workers; two were found to 
have positive NP cultures and/or PCRs. One 
individual had a single IgG titer of 1:256, and the other 
was seronegative. However, 18.3% of the remaining 
culture-negative, PCR-negative, asymptomatic sub- 
jects met the serologic criteria for acute infection as 
described above. The overall prevalence of antibody to 
C. pneumoniae was 81% in this population. 
These studies raise some questions about the 
sensitivity and specificity of MIF for the diagnosis of C. 
pneumoniae infection. Although the DNA homology 
between C. pneumoniae and C. trachomatis is less than 
5%, some parts of the genome, specifically the ompl 
gene, are highly conserved between the three 
chlamydial species. Thus there may be cross-reactions 
in the MIF test due to cross-reactions to the major 
outer membrane protein (MOMP) [24]. The MOMP 
does not a.ppear to be immunodominant in the 
serologic response to C. pneumoniae as it is for C. 
trachamatir [25-271. In the MIF test, the immuno- 
dominant protein is probably the MOMP, which is 
an important surface antigen of both chlamydial 
elementary and reticulate bodies 1281. The MOMP 
&splays genus-, species- and serovar-specific antigen 
determinants that are recognized during human in- 
fection and is known to cross-react with sera against 
either of the three species [29]. This may explain the 
culture-positive, MIF-negative children. 
When we examined sera &om these children with 
immunoblotting, we found that 95% reacted with 
several C. pneumoniae proteins, most frequently at 98 
kDa and 35 kDa, but less than 30% reacted with the 
MOMP [30]. If the specific antigenic determinants for 
C. pneumoniae are not expressed on the surface of the 
elementary body, sera &om these children may not react 
in the MIF test. Also, antibodies to the genus-specific 
lipopolysaccharide (LPS) antigen may cross-react in the 
MIF test with elementary bodies of the three species 
1281. Addtionally, it has been suggested that infections 
Table 4 PCR-EIA, cultural and serologic data for 104 healthy adults who were 
evaluated for the presence of asymptomatic C. pneurnoniae infection 
~~~ 
No (%)of 
indinduals w t h  No (%) w t h  No (%) with Total no (%) 
No inmvlduals posiave culture pre-exlstlng tltms indxating w t h  positive 
in the study and/or PCR results antlbody acute infection hters 
Male 71 0 48 (68) 13 (18) 61 (86) 
Female 33 2 (6 1) 17 (53) 6 (19) 23 (72) 
Total 104 2 (1 9) 65 (63) 19 (18) 84 (81) 
From Hyman et al [23] 
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with any of the chlamydial species may provoke an 
anamnestic response to the common antigenic deter- 
minants, resulting in multiple positive reactions in the 
MIF test when several chlamydial antigens are used 
[28,29]. This may explain the similar MIF titers to C. 
pneumoniae and C. trackomatis seen in the healthy adults 
reported by Kern et al [22] and also reported by Moss 
et al [31] in patients seen in a sexually transmitted 
disease (STD) clinic. 
As more studies of C. pneurnoniae infection are 
being done, similarities to C. trachornatis infection are 
becoming appreciated. Like C. trachomatis genital 
infection, many respiratory infections with C. pneu- 
moniae are subclinical and often of long duration 
[5,6,23]. Patients may remain infected for months 
following an acute respiratory infection [6]. This makes 
the demonstration of a four-fold titer rise c\lffcult 
because of timing of the specimens. Serology with 
paired sera also only offers a retrospective hagnosis, 
whch makes it difficult to manage patients pro- 
spectively or to assess the efficacy of treatment. 
Serology is not used for the hagnosis of genital C. 
trachomatis infections. One looks for the presence of the 
organism by culture or non-culture methods. The same 
may apply for C. pneumoniae. 
Non-culture methods 
Use of non-culture methods, including enzyme 
immunoassays (EIA), direct fluorescent antibody @FA) 
and DNA probes, for diagnosis of C. trachomatis 
infection has become common. A commercial PCR 
has recently been approved and released in the USA. 
These tests have been extensively evaluated for genital 
specimens in men and women and generally average 
80% sensitivity and > 95% speclficity compared to 
culture, with the exception of PCR, which may be 
10% more sensitive than culture. Culture itself is not 
100% sensitive. Unfortunately, there is not as yet a com- 
mercially available non-culture test for C. pneumoniae. 
As all the currently marketed EIAs use either a 
polyclonal antibody or genus-specific monoclonal 
antibody, they can detect C. pneumoniae. However, 
these tests have not been extensively evaluated in 
respiratory specimens, and p r e h n a r y  data suggest that 
they are not sufficiently sensitive to detect C. pneu- 
moniae. Chlrgwin et al 133 obtained nasopharyngeal 
swabs for testing with Chlamyhazyme (Abbott 
Diagnostics) fiom 91 children and adults with com- 
munity-acquired pneumonia. The EIA detected only 
two of 15 (13.3%) culture-positive patients. There were 
no false-positive results, although other investigators 
have reported false positives when used with throat 
cultures. Group A Streptococcus can give a positive 
reaction with Chlamydiazyme [32]. 
C. pneumoniae-specific monoclonal antibodies have 
also been used as DFA reagents. None of these reagents 
has been evaluated for direct detection of C. pneumoniae 
in smears of patient specimens fiom any source, 
including pharyngeal, NP and lower respiratory tract 
specimens. Grayston and colleagues found DFA 
staining of throat specimens to be less sensitive than cell 
culture for identlfylng C. pneumoniae infection 1331. We 
have had a similar experience and also have concern 
about specificity due to numerous artifacts and non- 
specific staining which can occur with respiratory 
specimens that contain mucus. 
The most promising non-culture methodology 
appears to be DNA amplification, specifically PCR. 
Most data available come from evaluations of in-house 
tests with limited numbers of patients, including 
culture positives. In 1992, Campbell et al [34] des- 
cribed a PCR assay, using genomic C. pneumoniae- 
speclfic primers. They found a very good correlation 
with culture. However, specimens were evaluated fiom 
only 36 patients, eight of whom were culture positive. 
This PCR assay was subsequently used in other clinical 
studies of respiratory infection fiom the University of 
Washington [2] and for the detection of C. pneumoniae 
DNA in atheroma specimens h m  patients [7]. All the 
atheroma specimens were culture negative, or culture 
was not attempted. However, these initial stuhes have 
not determined the sensitivity or specificity of PCR by 
testing a large number of c h c a l  specimens in parallel 
with cultures fiom symptomatic and asymptomatic 
individuals. 
The most extensively evaluated PCR is h m  
Gaydos and her colleagues at Johns Hopkins University. 
They have developed an assay using primers fiom the 
16s rRNA gene with the amphfication products being 
detected by EIA, offering a method that would be 
useful for screening large numbers of chical specimens 
[35,36]. They have compared PCR-EIA to culture in 
specimens fiom symptomatic and asymptomatic adults 
and children [36]. DFA staining of culture transport 
media was done to resolve discrepant specimens, 
usually secondary to the presence of non-viable organ- 
ism. They examined specimens fiom 56 patients with 
Table 5 Comparison of culture and PCR-EIA for 
detection of C. pneumoniae in nasopharyngeal specimens 
Culture 
Positive Negative 
PCR-EIA 
Positive 23 4 
Sensitivity: 74.2% 
Specificity: 96.2% 
Negative 8 101 
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respiratory infection and 80 asymptomatic persons; 35 
were positive by culture and/or PCR-EIA; 101 were 
negative by both assays; 23 specimens were culture and 
PCR positive (Table 5 ) .  When culture- and/or DFA- 
positive results were used as a reference or ‘gold 
standard’, the sensitivity and specificity of PCR-EIA 
were 76.5% and 99%, respectively. When PCR- and/or 
DFA-positive results were used as the reference, the 
sensitivity of culture was 87.5%. False-negative PCRS 
can result fiom the presence of inhibitors such as mucus 
or blood or loss of amplified DNA due to nucleases in 
the sample. Sometimes inhibition can be eliminated by 
fieeze-thawing or diluting the original sample. False- 
positive PCR results can also occur, usually due to 
amplicon contamination. The development of totally 
enclosed test systems would minimize this possibility. 
When the results of PCR and culture were compared 
to the results of single acute sera, only eight of 35 (23%) 
positive patients had diagnostic antibody titers. Of the 
80 asymptomatic patients, two of whom were culture 
and/or PCR positive, 15 (19%) had antibody titers 
considered to be diagnostic of acute infection. These 
results indicate that culture and/or PCR-EIA is more 
reliable for prompt diagnosis of C. pneumoniae infection 
than single-point serology alone. 
PCR and related methods also offer the potential 
to run multiple hybridizations to look for several 
organisms in the same sample. Co-infection of C. 
pneumoniae and other respiratory organisms, especially 
Mycoplasma pneumoniae, appears to be very common. 
Almost 20% of the children with culture-documented 
C. pneumoniae infection enrolled in the multicenter 
pneumonia treatment study were also infected with M. 
pneumoniae [4]. Clinically, one could not differentiate 
these children fi-om those dec ted  with either organism 
alone. A rapid, specific method of identifylng C. 
pneumoniae will enable the physician to diagnose these 
infections and offer appropriate therapy. 
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